Palo Alto Investors LP’s Biomarin Pharmaceutical Inc Position
Does Palo Alto Investors LP own Biomarin Pharmaceutical Inc (BMRN)? Yes — 685.2K shares worth $39M (+5.92% of its 13F portfolio) as of Q1 2026, down from 746.3K shares the prior filed quarter.
Position Value
$39M
Q1 2026
Shares
685.2K
% of Portfolio
+5.92%
Quarters Held
30
currently held
Position History BMRN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 685.2K | $39M | +5.92% |
| Q4 2025 | 746.3K | $44M | +6.17% |
| Q3 2025 | 754.0K | $41M | +7.56% |
| Q2 2025 | 840.5K | $46M | +9.83% |
| Q1 2025 | 991.2K | $70M | +13.34% |
| Q4 2024 | 1.07M | $70M | +10.87% |
| Q3 2024 | 1.09M | $77M | +9.95% |
| Q2 2024 | 1.13M | $93M | +10.78% |
| Q1 2024 | 1.13M | $99M | +11.18% |
| Q4 2023 | 1.50M | $145M | +13.04% |
| Q3 2023 | 1.83M | $162M | +15.33% |
| Q2 2023 | 1.83M | $159M | +12.82% |
| Q1 2023 | 1.83M | $178M | +14.75% |
| Q4 2022 | 1.89M | $195M | +16.64% |
| Q3 2022 | 1.98M | $168M | +13.25% |
| Q2 2022 | 2.06M | $171M | +14.89% |
| Q1 2022 | 2.14M | $165M | +12.75% |
| Q4 2021 | 2.21M | $196M | +12.49% |
| Q3 2021 | 2.21M | $171M | +10.32% |
| Q2 2021 | 2.21M | $185M | +10.18% |
| Q1 2021 | 2.21M | $167M | +9.49% |
| Q4 2020 | 2.16M | $189M | +9.91% |
| Q3 2020 | 1.73M | $132M | +7.23% |
| Q2 2020 | 1.41M | $173M | +10.41% |
| Q1 2020 | 1.54M | $130M | +10.93% |
| Q4 2019 | 2.02M | $171M | +9.41% |
| Q3 2019 | 2.21M | $149M | +9.92% |
| Q2 2019 | 2.61M | $223M | +10.85% |
| Q1 2019 | 2.64M | $235M | +9.79% |
| Q4 2018 | 2.56M | $218M | +11.60% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Palo Alto Investors LP’s full portfolio or all institutional holders of BMRN.